Logo of Medical Developments International (ASX:MVP)Latest Medical Developments International (ASX:MVP) News

Page 2
Page 2 of 2

MVP’s FY25 Surge, Revenue Up 18%, Eyes on Penthrox Volume Growth

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.
Ada Torres
21 Aug 2025

MVP Boosts Cashflow and Expands Penthrox Reach in Europe and Australia

Medical Developments International (MVP) reports positive operating cash flow in H2 FY25, driven by strong Penthrox sales and strategic distribution shifts in Europe. The company eyes further growth amid regulatory progress and efficiency gains.
Ada Torres
31 July 2025

Medical Developments International Accelerates Penthrox Growth with New European Deals

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.
Ada Torres
29 Apr 2025

Medical Developments Reports Strong Q2 FY25 Cash Flow and Revenue Growth

Medical Developments International has posted a robust improvement in operating cash flow and revenue for Q2 FY25, driven by higher demand and pricing for its flagship product Penthrox across Australia and Europe.
Ada Torres
31 Jan 2025